These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial. Colao A; Pivonello R; Rosato F; Tita P; De Menis E; Barreca A; Ferrara R; Mainini F; Arosio M; Lombardi G Clin Endocrinol (Oxf); 2006 Mar; 64(3):342-51. PubMed ID: 16487447 [TBL] [Abstract][Full Text] [Related]
13. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464 [TBL] [Abstract][Full Text] [Related]
14. Hormonal diagnosis of GH hypersecretory states. Grottoli S; Gasco V; Ragazzoni F; Ghigo E J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657 [TBL] [Abstract][Full Text] [Related]
15. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution. Jallad RS; Musolino NR; Salgado LR; Bronstein MD Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910 [TBL] [Abstract][Full Text] [Related]
16. [Heart disease in acromegaly. Study of 27 patients]. Marín F; Picó AM; Martínez JG; Domínguez JR; Alfayete R; Sogorb F Med Clin (Barc); 1996 Sep; 107(9):326-30. PubMed ID: 8984234 [TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular involvement in acromegaly. Apropos of 3 cases]. Cosnay P; Legras A; Garnier LF; Moquet B; Casset D; Fauchier JP; Brochier M Arch Mal Coeur Vaiss; 1987 Oct; 80(11):1643-50. PubMed ID: 3128208 [TBL] [Abstract][Full Text] [Related]
18. The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly. Gilbert JA; Miell JP; Chambers SM; McGregor AM; Aylwin SJ Clin Endocrinol (Oxf); 2005 Jun; 62(6):742-7. PubMed ID: 15943838 [TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular disturbances in acromegaly]. Fedrizzi D; Czepielewski MA Arq Bras Endocrinol Metabol; 2008 Dec; 52(9):1416-29. PubMed ID: 19197449 [TBL] [Abstract][Full Text] [Related]
20. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue? Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]